BioStock Investor Pitch: ExpreS2ion Biotechnologies
BioStock invites you to watch ExpreS2ion Biotechnologies' company presentation today at 10:00. The company develops protein-based vaccines using its platform technology ExpreS2. Today, the pipeline consists of projects in four indications: covid-19, breast cancer, influenza and malaria. The company is currently carrying out a rights issue of 73 million SEK to finance the completion of preclinical studies within the breast cancer project ES2B-C001, as well as to further develop the pipeline and strengthen its platform technology. CEO Bent U. Frandsen tells us more about ExpreS2ion's vision in